The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Knocking down barriers: advances in siRNA delivery
Open accessAbstract
In the 10 years that have passed since the Nobel prize-winning discovery of RNA interference (RNAi), billions of dollars have been invested in the therapeutic application of gene silencing in humans. Today, there are promising data from ongoing clinical trials for the treatment of age-related macular degeneration and respiratory syncytial virus. Despite these early successes, however, the widespread use of RNAi therapeutics for disease prevention and treatment requires the development of clinically suitable, safe and effective drug delivery vehicles. Here, we provide an update on the progress of RNAi therapeutics and highlight novel synthetic materials for the encapsulation and intracellular delivery of nucleic acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, there has been an exponential growth in the development of clinically suitable nonviral delivery systems for siRNA (19,20); we have taken advantage of these innovations to develop the LNP/RNA formulation and have now embarked on a more extensive evaluation of other nonviral delivery systems.”
From Nonviral delivery of self-amplifying RNA vaccines (2012) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There are limited published data on the in vivo delivery of self-amplifying RNA using nonviral delivery strategies (3,14,18), and none has taken advantage of the recently developed, clinically suitable delivery systems for siRNA (19,20).”
From Nonviral delivery of self-amplifying RNA vaccines (2012) · cites this paper as [20]
In the citing paper
“Additionally, endosomal membranes have been damaged or rebuilt using cell penetrating peptides to enhance the intracellular delivery of nucleic acids.313”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [313]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 5,018
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,004
Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting
Yoon, H. Y., Kim, H. R., Saravanakumar, G., Heo, R., Chae, S. Y., Um, W., Kim, K., Kwon, I. C., Lee, J. Y., Lee, D. S., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.008 · Cited by 68
MicroRNAs and cancer stem cells: Therapeutic approaches and future perspectives
Leal, J. A., & LLeonart, M. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.020 · Cited by 68
Liu, Z., Liang, X. D., Liu, H., Wang, Z., Jiang, T., Cheng, Y., Wu, M., Xiang, D., Li, Z., Wang, Z. L., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c06100 · Cited by 68
Triboelectric nanogenerators for self-powered drug delivery
Li, X., Tat, T., & Chen, J. (2021) · Trends in Chemistry · doi:10.1016/j.trechm.2021.04.009 · Cited by 68
Harnessing lipid nanoparticles for efficient CRISPR delivery
Yan, J., Kang, D. D., & Dong, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm00537e · Cited by 69
Size-Dependent Knockdown Potential of siRNA-Loaded Cationic Nanohydrogel Particles
Nuhn, L., Tomcin, S., Miyata, K., Mailänder, V., Landfester, K., Kataoka, K., & Zentel, R. (2014) · Biomacromolecules · doi:10.1021/bm501148y · Cited by 68
Yang, F., Huang, W., Li, Y., Liu, S., Jin, M., Wang, Y., Jia, L., & Gao, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.047 · Cited by 68
Nonviral delivery of genetic medicine for therapeutic angiogenesis
Park, H., Yang, F., & Cho, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.005 · Cited by 68
Single siRNA Nanocapsules for Enhanced RNAi Delivery
Yan, M., Liang, M., Wen, J., Liu, Y., Lu, Y., & Chen, I. S. Y. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304649a · Cited by 69
In Vivo Delivery Aspects of miRNA, shRNA and siRNA
Khatri, N., Rathi, M. N., Baradia, D., Trehan, S., & Misra, A. R. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i6.20 · Cited by 69
Altınoglu, S., Wang, M., & Xu, Q. (2015) · Nanomedicine · doi:10.2217/nnm.14.192 · Cited by 70
Yan, Y., Zhou, K., Xiong, H., Miller, J. B., Motea, E. A., Boothman, D. A., Liu, L., & Siegwart, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.001 · Cited by 68
Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems
Babu, A., Munshi, A., & Ramesh, R. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1313861 · Cited by 72
Mitochondrial Surface Engineering for Multidrug Resistance Reversal
Chen, W., Shi, K., Chu, B., Wei, X., & Qian, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b05188 · Cited by 68
Nanocarriers for Delivery of siRNA and Co-Delivery of siRNA and Other Therapeutic Agents
Zhao, J., & Feng, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.61 · Cited by 72
Lipidic lyotropic liquid crystals: Insights on biomedical applications
Blanco-Fernández, G., Blanco‐Fernandez, B., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102867 · Cited by 70
Liu, X., Liu, C., Catapano, C. V., Peng, L., Zhou, J., & Rocchi, P. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.001 · Cited by 67
FRET-Labeled siRNA Probes for Tracking Assembly and Disassembly of siRNA Nanocomplexes
Alabi, C. A., Love, K. T., Sahay, G., Stutzman, T., Young, W. T., Langer, R., & Anderson, D. G. (2012) · ACS Nano · doi:10.1021/nn3013838 · Cited by 67
Self-citationAn efficient and high-throughput electroporation microchip applicable for siRNA delivery
Huang, H., Wei, Z., Huang, Y., Zhao, D., Zheng, L., Cai, T.-J., Wu, M., Wang, W., Ding, X., Zhou, Z., et al. (2010) · Lab on a Chip · doi:10.1039/c0lc00195c · Cited by 67
Ma, C., Shi, L., Huang, Y., Shen, L., Peng, H. F., Zhu, X., & Zhou, G. (2017) · Biomaterials Science · doi:10.1039/c6bm00833j · Cited by 67
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
Peng, Y., Huang, J., Xiao, H. P., Wu, T., & Shuai, X. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s164611 · Cited by 68
Application of chitosan modified nanocarriers in breast cancer
Dubey, S. K., Bhatt, T., Agrawal, M., Saha, R. N., Saraf, S., Saraf, S., & Alexander, A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.11.095 · Cited by 66
Ma, D., Shen, H., Chen, F., Liu, W., Zhao, Y., Xiao, Z., Wu, X., Chen, B., Lu, J., Shao, D., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201319 · Cited by 66
Li, J., Mao, Z., Zhang, W., Su, H., Wang, Y., Tan, C., & Ji, L.-N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s67146 · Cited by 67
Tamura, A., Oishi, M., & Nagasaki, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.031 · Cited by 67
A new nucleic acid–based agent inhibits cytotoxic T lymphocyte–mediated immune disorders
Wang, C., Chung, W., Cheng, Y., Ying, N.-W., Peck, K., Chen, Y.-T., & Chung, W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.036 · Cited by 66
Boekhorst, B. C. M. T., Jensen, L., Colombo, S., Varkouhi, A. K., Schiffelers, R. M., Lammers, T., Storm, G., Nielsen, H. M., Strijkers, G. J., Foged, C., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.004 · Cited by 66
Quaternized starch-based carrier for siRNA delivery: From cellular uptake to gene silencing
Amar‐Lewis, E., Azagury, A., Chintakunta, R., Goldbart, R., Traitel, T., Prestwood, J., Landesman‐Milo, D., Peer, D., & Kost, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.031 · Cited by 66
Diels–Alder Cycloadditions on Synthetic RNA in Mammalian Cells
Pyka, A. M., Domnick, C., Braun, F., & Kath‐Schorr, S. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500302y · Cited by 66
Kowalski, P. S., Lintermans, L. L., Morselt, H. W. M., Leus, N. G. J., Ruiters, M. H. J., Molema, G., & Kamps, J. A. A. M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4001124 · Cited by 65
Reactive oxygen species (ROS)-responsive nanomedicine for RNAi-based cancer therapy
Li, Y., Bai, H., Wang, H., Shen, Y., Tang, G., & Yuan, P. (2017) · Nanoscale · doi:10.1039/c7nr06689a · Cited by 65
Wang, Y., Wu, Q., Wang, J., Li, L., Sun, X., Zhang, Z., & Zhang, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.024 · Cited by 65
Feng, J., Yu, W., Xu, Z., Hu, J., Liu, J., & Wang, F. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c04533 · Cited by 65
Peptide-Based Nanoassemblies in Gene Therapy and Diagnosis: Paving the Way for Clinical Application
Tarvirdipour, S., Huang, X., Mihali, V., Schoenenberger, C., & Palivan, C. G. (2020) · Molecules · doi:10.3390/molecules25153482 · Cited by 65
Selective Degradation of PD‐L1 in Cancer Cells by Enzyme‐Instructed Self‐Assembly
Wang, Y., Li, X., Zheng, D., Chen, Y., Zhang, Z., & Yang, Z. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102505 · Cited by 65
Makkar, S. K. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1675209 · Cited by 72
Zhao, Y., van Rooy, I., Hak, S., Fay, F., Tang, J., Davies, C. D. L., Skobe, M., Fisher, E. A. A., Radu, A., Fayad, Z. A., et al. (2013) · ACS Nano · doi:10.1021/nn404782p · Cited by 67
Kirtane, A. R., & Panyam, J. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.234 · Cited by 65
Kasiewicz, L. N., & Whitehead, K. A. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.023 · Cited by 65
Self-citationHou, W., Wei, P., Kong, L., Guo, R., Wang, S., & Shi, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00710d · Cited by 65
Advances in nanomicelles for sustained drug delivery
Amirmahani, N., Mahmoodi, N. O., Galangash, M. M., & Ghavidast, A. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.06.050 · Cited by 66
Liu, J., Zhang, Y., Zeng, Q., Zeng, H., Liu, X., Wu, P.-H., Xie, H., He, L., Long, Z., Lu, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw6499 · Cited by 65
Shi, P., Li, M., Song, C., Qi, H., Ba, L., Cao, Y., Zhang, M., Xie, Y., Ren, J., Wu, J., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.024 · Cited by 64
Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
Wu, T., & Zhou, S. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10083 · Cited by 67
Malih, S., Saidijam, M., & Malih, N. (2015) · Tumor Biology · doi:10.1007/s13277-015-4572-y · Cited by 64
Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA Delivery
Zeng, H., Johnson, M. E., Oldenhuis, N. J., Tiambeng, T. N., & Guan, Z. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00233 · Cited by 64
Recent advances of biomaterials in biotherapy
Li, L., He, Z., Wei, X., & Wei, Y.-Q. (2016) · Regenerative Biomaterials · doi:10.1093/rb/rbw007 · Cited by 64
Suzuki, Y., Hyodo, K., Suzuki, T., Tanaka, Y., Kikuchi, H., & Ishihara, H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.016 · Cited by 64
Maurer, V., Altin, S., Seleci, D. A., Zarinwall, A., Temel, B., Vogt, P. M., Strauß, S., Stahl, F., Scheper, T. H., Bucan, V., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030394 · Cited by 65
Skin Delivery of siRNA Using Sponge Spicules in Combination with Cationic Flexible Liposomes
Liang, X., Zhang, J., Ou, H., Chen, J., Mitragotri, S., & Chen, M. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.003 · Cited by 63
Kim, H., Yuk, S. A., Dieterly, A. M., Kwon, S., Park, J., Meng, F., Gadalla, H. H., Cadena, M. J., Lyle, L. T., & Yeo, Y. (2021) · ACS Nano · doi:10.1021/acsnano.0c08694 · Cited by 63
Advances in cancer theranostics using organic-inorganic hybrid nanotechnology
Chen, G., Qian, Y., Zhang, H., Ullah, A., He, X., Zhou, Z., Fenniri, H., & Shen, J. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101003 · Cited by 63
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies
Karlsson, J. E., Luly, K. M., Tzeng, S. Y., & Green, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113999 · Cited by 65
Kumar, R., Le, N., Oviedo, F., Brown, M. E., & Reineke, T. M. (2022) · JACS Au · doi:10.1021/jacsau.1c00467 · Cited by 63
Tang, L., Zhang, R., Wang, Y., Zhang, X., Yang, Y., Zhao, B., & Yang, L. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.013 · Cited by 63
Ongoing Clinical Trials of Nonviral siRNA Therapeutics
Narasipura, E. A., VanKeulen‐Miller, R., Ma, Y., & Fenton, O. S. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00205 · Cited by 66
Self-Catalyzed Degradable Cationic Polymer for Release of DNA
Truong, N. P., Jia, Z., Burgess, M. L., Payne, L., McMillan, N. A. J., & Monteiro, M. J. (2011) · Biomacromolecules · doi:10.1021/bm2007423 · Cited by 63
Press, A. T., Traeger, A., Pietsch, C., Mosig, A. S., Wagner, M., Clemens, M. G., Jbeily, N., Koch, N., Gottschaldt, M., Bézière, N., et al. (2014) · Nature Communications · doi:10.1038/ncomms6565 · Cited by 63
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles
Leber, N., Kaps, L., Aslam, M., Schupp, J., Brose, A., Schaeffel, D., Fischer, K., Diken, M., Strand, D. J., Koynov, K., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.006 · Cited by 63
Prabhakar, N., Zhang, J., Desai, D., Casals, E., Gulin-Sarfraz, T., Näreoja, T., Westermarck, J. K., & Rosenholm, J. M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s120611 · Cited by 63
Shen, J., Liu, H., Mu, C., Wolfram, J., Zhang, W., Kim, H.-C., Zhu, G., Hu, Z., Ji, L.-N., Liu, X., et al. (2017) · Nanoscale · doi:10.1039/c7nr00377c · Cited by 63
Thijssen, M. F., Brüggenwirth, I. M. A., Gillooly, A. R., Khvorova, A., Kowalik, T. F., & Martins, P. N. A. (2018) · Liver Transplantation · doi:10.1002/lt.25383 · Cited by 67
Virus-Inspired Function in Engineered Protein Cages
Edwardson, T. G. W., & Hilvert, D. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03705 · Cited by 64
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
Renner, D. B., Frey, W. H., & Hanson, L. R. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.037 · Cited by 62
Internalization pathways of nanoparticles and their interaction with a vesicle
Chen, X., Tian, F., Zhang, X., & Wang, W. (2013) · Soft Matter · doi:10.1039/c3sm50931a · Cited by 62
Tamura, A., & Yui, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.006 · Cited by 62
A Cell-penetrating Helical Polymer For siRNA Delivery to Mammalian Cells
Gabrielson, N. P., Lu, H., Yin, L., Kim, K. H., & Cheng, J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.78 · Cited by 62
A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery
Chen, H., Liu, X., Dou, Y., He, B., Liu, L., Wei, Z., Li, J., Wang, C., Mao, C., Zhang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.035 · Cited by 63
Layer‐by‐Layer Nanoparticles as an Efficient siRNA Delivery Vehicle for SPARC Silencing
Tan, Y., Mundargi, R. C., Chen, M. H. A., Leßig, J., Neu, B., Venkatraman, S. S., & Wong, T. T. L. (2014) · Small · doi:10.1002/smll.201303201 · Cited by 62
Biomimetic RNA‐Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells
Wang, Z., Wang, Z., Liu, D., Yan, X., Wang, F., Niu, G., Yang, M., & Chen, X. S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309985 · Cited by 62
Lin, Q., Jin, C. S., Huang, H., Ding, L., Zhang, Z., Chen, J., & Zheng, G. (2014) · Small · doi:10.1002/smll.201303842 · Cited by 62
Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids
Molla, M. R., & Levkin, P. A. (2015) · Advanced Materials · doi:10.1002/adma.201502888 · Cited by 62
Photocleavable Hydrogels for Light‐Triggered siRNA Release
Huynh, C. T., Nguyen, M. K., Tonga, G. Y., Longé, L., Rotello, V. M., & Alsberg, E. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500778 · Cited by 62
Gallon, E., Matini, T., Sasso, L., Mantovani, G., Armiñán, A., Sanchis, J., Caliceti, P., Alexander, C., Vicent, M. J., & Salmaso, S. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00286 · Cited by 64
Balmayor, E. R., Geiger, J. P., Koch, C., Aneja, M. K., van Griensven, M., Rudolph, C., & Plank, C. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0171 · Cited by 62
Wang, Y., Newman, M. R., & Benoit, D. S. W. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.02.023 · Cited by 65
Zhang, R., Gao, S., Wang, Z., Han, D., Liu, L., Ma, Q., Tan, W., Tian, J., & Chen, X. S. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201701027 · Cited by 61
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
Uddin, N., Binzel, D. W., Shu, D., Fu, T., & Guo, P. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.019 · Cited by 61
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Cryan, S., McKiernan, P. J., Cunningham, & Greene, C. M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s47551 · Cited by 64
Paolo, D. D., Ambrogio, C., Pastorino, F., Brignole, C., Martinengo, C., Carosio, R., Loi, M., Pagnan, G., Emionite, L., Cilli, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.142 · Cited by 64
Engineering DNA scaffolds for delivery of anticancer therapeutics
Sun, W., & Gu, Z. (2015) · Biomaterials Science · doi:10.1039/c4bm00459k · Cited by 61
Bioanalysis of siRNA and Oligonucleotide Therapeutics in Biological Fluids and Tissues
Tremblay, G. A., & Oldfield, P. R. (2009) · Bioanalysis · doi:10.4155/bio.09.66 · Cited by 61
Cutaneous short-interfering RNA therapy
Geusens, B., Sanders, N. N., Prow, T. W., Gele, M. V., & Lambert, J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903304032 · Cited by 61
Haggag, Y. A., Matchett, K. B., Dakir, E. H., Buchanan, P., Osman, M. A., El‐Gizawy, S. A., El‐Tanani, M., Faheem, A., & McCarron, P. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.006 · Cited by 61
Werfel, T. A., Jackson, M. A., Kavanaugh, T. E., Kirkbride, K. C., Miteva, M., Giorgio, T. D., & Duvall, C. L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.389 · Cited by 61
Qian, Y., Liang, X., Yang, J., Zhao, C., Nie, W., Liu, L., Yi, T., Jiang, Y., Geng, J., Zhao, X., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12393 · Cited by 63
Wechsler, M. E., Ramirez, J. E. V., & Peppas, N. A. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b02196 · Cited by 61
Yu, T., Liu, X., Bolcato‐Bellemin, A., Wang, Y., Liu, C., Erbacher, P., Qu, F., Rocchi, P., Behr, J., & Peng, L. (2012) · Angewandte Chemie · doi:10.1002/ange.201203920 · Cited by 61
RetractedHuang, H., Kuo, W., Chou, M., & Huang, Y. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33055 · Cited by 61
Singh, A., Talekar, M., Tran, T.-H., Samanta, A., Sundaram, R., & Amiji, M. M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01083c · Cited by 60
siRNA Transfection with Calcium Phosphate Nanoparticles Stabilized with PEGylated Chelators
Giger, E. V., Castagner, B., Räikkönen, J., Mönkkönen, J., & Leroux, J. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200088 · Cited by 60
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
Ianza, A., Sirico, M., Bernocchi, O., & Generali, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641449 · Cited by 62
Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
Xu, M., Liu, Y., Lin, Y., Lu, Y., Bi, X., Jiang, T., Deng, W., Zhang, L., Yi, W., Xie, Y., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01615-2 · Cited by 62
Mehta, M. J., Kim, H. J., Lim, S. B., Naito, M., & Miyata, K. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202300366 · Cited by 61
Lee, S. J., Min, H. S., Ku, S. H., Son, S., Kwon, I. C., Kim, S. H., & Kim, K. (2014) · Nanomedicine · doi:10.2217/nnm.14.99 · Cited by 62
Alam, M. R., Ming, X., Dixit, V., Fisher, M. H., Chen, X. S., & Juliano, R. L. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0211 · Cited by 60
Tuning Physical Properties of Nanocomplexes through Microfluidics-Assisted Confinement
Ho, Y., Grigsby, C. L., Zhao, F., & Leong, K. W. (2011) · Nano Letters · doi:10.1021/nl200862n · Cited by 61
Lipid‐Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo
Dong, Y., Eltoukhy, A. A., Alabi, C. A., Khan, O. F., Omid Veiseh, A., Dorkin, J. R., Sirirungruang, S., Yin, H., Tang, B. C., Pelet, J. M., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400054 · Cited by 60
Self-citationEzzat, K., Zaghloul, E. M., Andaloussi, S. E., Lehto, T., El-Sayed, R., Magdy, T., Smith, C. I. E., & Langel, Ü. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.006 · Cited by 60
Bali, K. K., Selvaraj, D., Satagopam, V., Lu, J., Schneider, R., & Kuner, R. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302797 · Cited by 60
Metadata
- Authors
- Whitehead, K. A., Langer, R., & Anderson, D. G.
- Affiliations
- Massachusetts Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Corresponding author
- Anderson, Daniel G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-02
- Volume
- 8
- Issue
- 2
- Pages
- 129-138
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC7097568
- OpenAlex
- W1964146045
- Cited by
- 3,115
- References
- 106
- Citations by year
- 2026: 96 · 2025: 114 · 2024: 150 · 2023: 120 · 2022: 159 · 2021: 207 · 2020: 148 · 2019: 191 · 2018: 183 · 2017: 199 · 2016: 220 · 2015: 218 · 2014: 240 · 2013: 233 · 2012: 222
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- siRNA delivery, RNA interference therapy, gene silencing, nucleic acid encapsulation, intracellular delivery, age-related macular degeneration, respiratory syncytial virus, clinical trials
- MeSH terms
- Animals, Clinical Trials as Topic, Humans, Liposomes, Drug Delivery Systems, RNA Interference, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
